Edgewise Therapeutics, Inc. (EWTX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $552.60M | +13.5% |
| 2024 | $486.82M | +43.2% |
| 2023 | $340.04M | -7.4% |
| 2022 | $367.10M | +28.7% |
| 2021 | $285.23M | +117.5% |
| 2020 | $131.14M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $552.60M | +13.5% |
| 2024 | $486.82M | +43.2% |
| 2023 | $340.04M | -7.4% |
| 2022 | $367.10M | +28.7% |
| 2021 | $285.23M | +117.5% |
| 2020 | $131.14M | — |